We invite you to share your endeavors with the healthcare community at the 2015 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation of America’s Clinical & Research Conference by submitting an abstract online. Submission deadline is September 15, 2015.


  • Increase Your Prestige. Seize the opportunity to present your work at one of the most highly regarded conferences in the field to over 2,000 attendees.
  • Gain added exposure for your work. Accepted abstracts will be published in the Inflammatory Bowel Diseases journal and scheduled for oral or poster presentation.
  • Share with your colleagues. Reception in conjunction with poster viewing encourages visibility.
  • Receive an award or grant. A limited number of travel grants are being offered to nurses and GI fellows. The travel grant includes free registration and a $500 scholarship to cover travel. Applicants must submit an abstract to qualify. Everyone - including young investigators, nurses, basic scientists, and clinical researchers - is encouraged to apply. Applicants must submit an abstract to qualify. 

Participants interested in presenting data should submit abstracts online by September 15, 2015, 11:59PM ET. Abstracts are subject to acceptance by the Scientific Abstract Review Committee. Abstracts selected for presentation will be published in Inflammatory Bowel Diseases, February 2016 Supplement, and scheduled for oral or poster presentation. Only abstracts received by the submission deadline will be published. Acceptance notifications will be sent on October 16, 2015.
Abstracts will be accepted in the following categories: Clinical or Pediatric or Basic Science or Nursing. Please indicate which category is appropriate by checking the appropriate box in the online submission system.

Clinical Abstracts Categories
C1. Investigator-initiated Controlled Clinical Trials
C2. Investigator-initiated Uncontrolled Clinical Trials
C3. Pharma-initiated Clinical Trials
C4. Procedures and Diagnostics
C5. Epidemiology and Outcomes Research
C6. Patient Care and Complications of Therapy
C7. Clinical Case Reports
C8. Surgery

Pediatric Clinical Abstracts Categories
P1. Investigator-initiated Controlled Clinical Trials
P2. Investigator-initiated Uncontrolled Clinical Trials
P3. Pharma-initiated Clinical Trials
P4. Procedures and Diagnostics
P5. Epidemiology and Outcomes Research
P6. Patient Care and Complications of Therapy
P7. Clinical Case Reports
P8. Pediatric Surgery

Basic Research Abstract Categories
B1. Genetics
B2. Microbiology
B3 Innate Immune System
B4. Adaptive Immune System
B5. Cytokines, Chemokines, and Cell Signaling
B6. Epithelial Cells
B7. Animal Models

Nursing Abstract Categories
N1. Clinical Education
N2. Clinical Basic Research
N3. Clinical Practice
N4. Other

Abstract Guidelines

Accepted format:

  • Abstracts must be in English
  • Word document format
  • 9 point Arial font
  • 500 word count limit
  • Use a concise title
  • List affiliations of author(s) as briefly as possible, with city, province and country
    • The system can accommodate up to 20 total authors
  • Use standard and well-accepted abbreviations
  • When listing references, use standard and well-accepted formats
  • Abstract content should be single-spaced and typed in lower case
  • Abstracts shall be of original research and contain a concise statement of study aim
  • Please include the following four (4) parts of your abstract:
    • Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable

Previous Presentation, Publication and Duplication of Abstracts

***Abstracts that will NOT be considered for presentation***

  • Abstracts that have been or will be presented before the 2015 Advances in IBD Conference
  • Abstracts that have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline
  • Abstracts that have been duplicated in any way
  • Abstracts may not be submitted to more than one category
  • Abstracts that have been submitted to the Advances in IBD Conference in previous years, and have not been accepted for poster or oral presentation, are eligible for submission but must contain new, additional information to be considered
  • Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author

Presentation Formats

  • Oral presentations
  • Poster presentations

Abstracts for oral or poster presentations will be chosen by the Scientific Abstract Review Committee.
Oral Abstract Presentation: Oral abstracts will be 10 minute presentations, which is the total allotted time. Therefore presenters must plan accordingly to schedule audience participation and questions. Employees of commercial interests are not preferred oral abstract presenters, but authors on the abstract who are not employees of commercial interests are eligible to present their data, if selected.
Poster Abstract Presentation: Poster presentations encourage interaction and exchange between authors and attendees. Detailed information regarding presentation times will be forthcoming.

Inclusion of Quick Response (QR) Codes

A QR code (abbreviation for Quick Response Code) is a type of bar code that you can scan with your smart phone or mobile device. Data such as a PDF version of a research poster or a website’s URL pointing to an online version of the research poster is sent to your phone when you scan the code. To scan, you will need a QR code reader installed on your device, of which there are many free versions of this software available for download.
The conference does permit use of QR codes on printed posters in the poster hall, as long as the code facilitates the user/scanner to view:*

  • a PDF version of the poster on their mobile device (ie, ePoster), and/or
  • a website URL pointing to an online version the research poster

* Any other use of a QR code is prohibited, and violation of this policy could result in a sanction from submitting abstracts to this conference for the submitting authors and/or other restrictions from participation at this conference.
Although preliminary research1 on QR codes has demonstrated increased interactions through their use, an average of 3-5 minutes may be required of presenters to explain and demonstrate this technology.  Thus, poster presenters should be properly prepared for this possibility on site.
Additionally, the conference bears no responsibility for the generation or oversight of QR codes for any specific poster.  The decision to include, and implementation of, QR codes on specific posters is the sole responsibility of the poster presenter.

  • J.R. Meloro, ISMPP CMPP, Kristen Letrent, PharmD, BCPS, ISMPP CMPP, Joanne C. Ryan, PhD, RN, Josephine A. Sollano, DrPH, MPH, Cate Scott, PhD. Pfizer Oncology Global Medical Communications, New York, NY, La Jolla, CA, Walton Oaks, UK. Digital Dissemination of Scientific Poster Presentations via Quick Response (QR) Codes: Implementation and Analytics Quick Response (QR) Codes: Implementation and Analytics. Presented at the 9th Annual Meeting of the International Society for Medical Publication Professionals, Baltimore, MD, USA, April 29-May 1, 2013.

Commitment to Present

Submission of an abstract constitutes a commitment by the author(s) to present if it is accepted. Failure to present, if not justified, will jeopardize acceptance of future abstract submissions. Only the primary author or co-author may present the accepted abstract at the 2015 Advances in IBD Conference. This conference does not provide honoraria for abstract presenters.
The conference will withdraw abstracts upon written notification from the submitting author by October 30, 2015. If circumstances prevent attendance, the primary author must arrange for the presentation to be given by a co-author. Acceptance of the abstract obligates the author to present the paper.

Travel Grants

A limited number of travel grants will be offered to GI fellows-in-training and nurses to attend the AIBD conference. These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) a scholarship of $500.

A limited number of international travel grants will be offered to young investigators who attend the AIBD conference. These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) additional scholarship funds to cover incidentals.

For travel grant eligibility, the first author must meet the following criteria to be considered for the award:

  • Candidate must submit a well-written, concise, and accurate abstract
  • Candidate must show original research of major importance in the field of medical/clinical Inflammatory Bowel Diseases conducted by themselves and co-investigators (if any)
  • Candidate must show relevance of the work to a current problem in patients involving Inflammatory Bowel Diseases
  • Candidate must be registered for the conference and present during the scheduled poster presentation times
  • For fellows-in-training, candidate for the award must be in training in a recognized GI training program. Candidate may be asked to provide a letter of support from his/her Program Director indicating their eligibility for the award

All young investigators, GI fellows-in-training and nurses eligible and interested for consideration for these awards must indicate so by answering “yes” when asked during the official abstract submission process. Travel grants will be based on abstract review score as determined by the Scientific Abstract Review Committee.

Important Abstract Dates

Abstract Submission Deadline
September 15, 2015
Abstract Notifications Mailed
October 16, 2015
Abstract Presenter Registration Deadline
November 10, 2015
Presentation Dates
December 10-12, 2015


Endorsed by